Filing metadata

Accession number
0000950170-24-087461
Form type
Form 3
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Jul 29, 2024
Reporting period
Jul 23, 2024
Description
Initial ownership

Explore SEC Filings Hub